Integer Holdings Corporation (NYSE:ITGR – Get Free Report) has been given a consensus rating of “Hold” by the ten analysts that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and four have assigned a buy rating to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $102.00.
Several research analysts have recently commented on the company. Wells Fargo & Company raised their price target on Integer from $72.00 to $84.00 and gave the stock an “equal weight” rating in a research report on Friday, February 20th. Raymond James Financial restated an “outperform” rating and set a $101.00 target price on shares of Integer in a research note on Monday. Truist Financial boosted their target price on Integer from $95.00 to $97.00 and gave the company a “buy” rating in a report on Friday, February 20th. Citigroup increased their price target on shares of Integer from $75.00 to $92.00 and gave the stock a “neutral” rating in a research note on Friday. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Integer in a report on Monday, December 29th.
Check Out Our Latest Report on ITGR
Institutional Inflows and Outflows
Integer Stock Up 1.4%
Shares of ITGR stock opened at $86.93 on Wednesday. The stock has a 50 day moving average of $83.34 and a 200 day moving average of $87.72. Integer has a twelve month low of $62.00 and a twelve month high of $129.53. The stock has a market cap of $3.05 billion, a P/E ratio of 30.29, a P/E/G ratio of 1.46 and a beta of 0.77. The company has a current ratio of 3.32, a quick ratio of 2.23 and a debt-to-equity ratio of 0.69.
Integer (NYSE:ITGR – Get Free Report) last posted its quarterly earnings data on Thursday, February 19th. The medical equipment provider reported $1.76 EPS for the quarter, topping the consensus estimate of $1.70 by $0.06. The company had revenue of $472.06 million during the quarter, compared to analyst estimates of $462.73 million. Integer had a return on equity of 13.26% and a net margin of 5.55%.Integer’s quarterly revenue was up 5.0% on a year-over-year basis. During the same period in the previous year, the business earned $1.43 EPS. Integer has set its FY 2026 guidance at 6.290-6.780 EPS. As a group, sell-side analysts expect that Integer will post 6.01 EPS for the current year.
Integer declared that its board has authorized a stock buyback plan on Tuesday, November 4th that allows the company to buyback $200.00 million in shares. This buyback authorization allows the medical equipment provider to repurchase up to 8.3% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s management believes its stock is undervalued.
About Integer
Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.
Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.
Featured Articles
- Five stocks we like better than Integer
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This makes me furious
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
